Semaglutide pharmacokinetics Injectable semaglutide has a half-life of approximately 7 days, or 165 to 184 hours
Lead author and pharmacist, Associate Professor Luke Grzeskowiak, says that in 2022 alone, more than 6,000 women began treatment on GLP-1s, and over 90% of those did not have a diabetes diagnosis
Muscle loss on GLP-1s isn't inevitable
Lifestyle Factors: Your GLP-1's Best Partner While GLP-1 medications are incredible at reducing appetite, they aren't magic bullets
Whether its oral semaglutide or other evidence-based therapies, every recommendation is grounded in science and clinical experience
In fact, a 2024 Centers for Disease Control study noted an impressive 26.5% GLP-1 adoption rate in American adults diagnosed with diabetes